Cano-Ortiz Antonio, Sánchez-Ventosa Álvaro, González-Cruces Timoteo, Villalba González Marta, López Pérez María Dolores, Díaz-Ramos José Carlos, Prados Carmona Juan J, Tejerina Fernández Victor, Elies Amat Daniel, Villarrubia Alberto
Department of Anterior Segment, Cornea and Refractive Surgery, Hospital Arruzafa, 14012 Cordoba, Spain.
Department of Health and Biomedical Sciences, Universidad Loyola Andalucía, 41704 Sevilla, Spain.
J Clin Med. 2024 Dec 5;13(23):7404. doi: 10.3390/jcm13237404.
This study aimed to evaluate the initial clinical outcomes of and patient satisfaction with the newly introduced extended monofocal Evolux™ intraocular lens following cataract surgery. A retrospective study was conducted, involving 18 patients (36 eyes) who received Evolux™ lenses bilaterally. The inclusion criteria comprised individuals over 40 years old with no active eye diseases, excluding cataracts, and no postoperative complications. Various parameters were evaluated, including distance, intermediate, and near visual acuity; refraction; defocus curves; dependency on spectacles; and patient satisfaction. Patient satisfaction and visual quality of life were measured using the Catquest-9SF and QOV questionnaires. The average age of the patients was 72.7 years, with the majority being women (77.8%). The results demonstrated excellent postoperative visual acuity at different distances. The mean logMAR values for uncorrected visual acuity were -0.04 for distance vision, 0.15 for intermediate vision, and 0.35 for near vision. The defocus curve indicated good tolerance, with visual acuity exceeding 20/20 in significant defocus ranges. Most patients expressed high satisfaction with their vision without spectacles, particularly for distance and intermediate vision. The need for spectacles for near vision was notably reduced. Furthermore, there was a low incidence of photic phenomena like halos and glare, contributing to the overall high patient satisfaction. Evolux™ lenses were found to be an effective choice for cataract surgery, providing excellent visual acuity at various distances and high patient satisfaction.
本研究旨在评估白内障手术后新引入的扩展单焦点Evolux™人工晶状体的初始临床效果及患者满意度。进行了一项回顾性研究，纳入18例（36眼）双侧植入Evolux™晶状体的患者。纳入标准包括年龄超过40岁、无活动性眼病（不包括白内障）且无术后并发症的个体。评估了各种参数，包括远、中、近视力；屈光；散焦曲线；对眼镜的依赖程度；以及患者满意度。使用Catquest-9SF和QOV问卷测量患者满意度和视觉生活质量。患者的平均年龄为72.7岁，大多数为女性（77.8%）。结果显示，术后不同距离的视力均极佳。未矫正视力的平均logMAR值，远视力为-0.04，中视力为0.15，近视力为-0.35。散焦曲线表明耐受性良好，在显著散焦范围内视力超过20/20。大多数患者对不戴眼镜时的视力表示高度满意，尤其是远视力和中视力。近视力对眼镜的需求显著减少。此外，光晕和眩光等光现象的发生率较低，这使得患者总体满意度较高。研究发现，Evolux™晶状体是白内障手术的有效选择，能在不同距离提供极佳的视力，并具有较高的患者满意度。
